Eli Lilly & Co.
Symbol: LLY (NYSE)
810.97
▲ (0.25%) 2.009
Company Description:
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key Stats
- Today's Open: $806.93
- Today's High: $812.805
- Today's Low: $803.519
- Today's Volume: 390.58K
- Yesterday Close: $808.96
- Yesterday High: $809.41
- Yesterday Low: $799.77
- Yesterday Volume: 2.28M
- Last Min Volume: 1.60K
- Last Min High: $811.47
- Last Min Low: $810.997
- Last Min VWAP: $811.34461
Company Profile
- Name: Eli Lilly & Co.
- Website: https://www.lilly.com
- Listed Date: 1970-07-09
- Location: INDIANAPOLIS, IN
- Market Status: Active
- CIK Number: 0000059478
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $725.20B
- Round Lot: 100
- Outstanding Shares: 896.46M
- Asset Type: CS
RECENT FILINGS FOR LLY
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-14 | 4 | View |
| 2025-10-10 | 4 | View |
| 2025-10-10 | 144 | View |
| 2025-10-09 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-07 | 4 | View |
| 2025-10-06 | 4 | View |
| 2025-10-06 | 144 | View |
| 2025-10-03 | SCHEDULE 13G/A | View |
| 2025-10-03 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 144 | View |
| 2025-10-01 | 144 | View |
| 2025-10-01 | 4 | View |
| 2025-09-22 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-18 | 144 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
Latest News on LLY